Results 131 to 140 of about 9,352,293 (347)

Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Children with inflammatory bowel diseases (IBD) have limited access to the available advanced therapies, given the lengthy gap between adult and pediatric approval. We aimed to review key hurdles for pediatric trials and recommend practical solutions.
Dan Turner   +21 more
wiley   +1 more source

Therapy de‐escalation in pediatric patients with inflammatory bowel disease in remission: Data analysis from the CEDATA registry

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives There are no standardized criteria about stepping down from combination therapy (immunomodulator and tumor necrosis factor (TNF)‐alpha‐inhibitors) in children with inflammatory bowel disease (IBD) to reduce risk for side effects. Our aim was to describe how de‐escalation has been performed in a large pediatric cohort and to find ...
Sila Cekin   +5 more
wiley   +1 more source

Crohn Disease: Epidemiology, Diagnosis, and Management

open access: yesMayo Clinic proceedings, 2017
J. Feuerstein, A. Cheifetz
semanticscholar   +1 more source

Fatigue in pediatric inflammatory bowel disease: Explained by transdiagnostic and disease‐focused factors

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective Fatigue is highly prevalent in children with inflammatory bowel disease (IBD), even during clinical remission. This suggests a role for transdiagnostic factors—lifestyle, psychological, and social influences not specific to the disease.
Maartje D. Stutvoet   +6 more
wiley   +1 more source

Amino acid-responsive Crohn's disease: a case study

open access: yesClinical and Experimental Gastroenterology, 2010
Alvin Stein1, Marty Hinz2, Thomas Uncini31Stein Orthopedic Associates, Plantation, FL, USA; 2Clinical Research, NeuroResearch Clinics Inc., Cape Coral, FL, USA; 3Laboratory, Fairview Regional Medical Center-Mesabi, Hibbing, MN, USAPurpose: This paper ...
Alvin Stein, Marty Hinz, Thomas Uncini
doaj  

Combined Restitutive Therapy for Treatment of Immunosuppressive Refractory Crohn Disease

open access: green, 2013
Jason R. Goldsmith   +3 more
openalex   +2 more sources

Crohn S Disease and Acne Fulminans as Associated Disoders (Case Report) [PDF]

open access: diamond, 2015
Klaudia Péčová   +3 more
openalex   +1 more source

Adequate vitamin D is associated with favorable disease outcome in children with inflammatory bowel disease receiving anti‐tumor necrosis factor alpha therapy

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Deficiency of serum 25‐hydroxyvitamin D [25(OH)D] was associated with decreased short‐term response to anti‐tumor necrosis factor‐alpha (TNF‐α) agents in adults with inflammatory bowel disease (IBD). The aim of this study was to evaluate the association between serum 25(OH)D levels and the outcome of children with IBD undergoing ...
Adi Anafy   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy